Correspondence 0000950170-24-042608 from Perspective Therapeutics, Inc. (CATX) (CIK 0000728387) (CATX)
Perspective Therapeutics, Inc. (CATX) (CIK 0000728387)
Date: April 8, 2024 · CIK: 0000728387 · Accession: 0000950170-24-042608
AI Filing Summary & Sentiment
File numbers found in text: 333-278362
Letter
PERSPECTIVE THERAPEUTICS, INC.
2401 Elliott Avenue, Suite 320
Seattle, Washington 98121
April 8, 2024
VIA EDGAR
Office of Industrial Applications and Services
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Conlon Danberg
Re: Perspective Therapeutics, Inc.
Registration Statement on Form S-3
Filed March 29, 2024
File No. 333-278362
Request for Acceleration of Effective Date
To Whom it May Concern,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Perspective Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on April 9, 2024, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted.
Very truly yours,
PERSPECTIVE THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
PERSPECTIVE THERAPEUTICS, INC.
2401 Elliott Avenue, Suite 320
Seattle, Washington 98121
April 8, 2024
VIA EDGAR
Office of Industrial Applications and Services
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Conlon Danberg
Re: Perspective Therapeutics, Inc.
Registration Statement on Form S-3
Filed March 29, 2024
File No. 333-278362
Request for Acceleration of Effective Date
To Whom it May Concern,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Perspective Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on April 9, 2024, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted.
Very truly yours,
PERSPECTIVE THERAPEUTICS, INC.
By:
/s/ Johan (Thijs) Spoor
Name:
Johan (Thijs) Spoor
Title:
Chief Executive Officer